Presbyopia Therapies, LLC Report issue

For profit Phase 2
Founded: Coronado CA United States (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2015
NCT02554396
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now